Tag:

Before

News

Rotorua triple murder trial delayed: New date set for Justin Jeffries case

by Rachel Morgan News Editor
written by Rachel Morgan News Editor

Justin Matthew Jeffries, a 52-year-old man from Mamaku near Rotorua, is facing trial for a triple murder after pleading not guilty on the grounds of insanity. The legal proceedings have encountered scheduling delays, pushing the anticipated start of the trial further into next year.

Details of the Charges

Jeffries is charged with the murder of 59-year-old Michelle Nicola Schiller on September 19, as well as the murders of Jessie Florence Currin, 78, and Glendon Brent Currin, 77, on September 23.

Beyond the homicide charges, the court has cited additional offenses. Jeffries is accused of wounding Adam Sour with intent to cause grievous bodily harm on September 23 in Rotorua.

He also faces charges for unlawfully using Michelle Schiller’s bank card with the intent to obtain property and entering a building on Old Taupo Rd with the intent to commit an imprisonable offense.

Did You Know? The case involves multiple crime scenes, including a flat on Old Taupo Rd where Michelle Schiller was found and a property on Russell Cres where the Currins lived.

The Insanity Defense and Expert Evidence

Defense lawyer Andy Hill has informed the court that a trial is necessary to determine the issue of insanity. While many facts in the case are agreed upon, the trial is expected to focus heavily on expert evidence.

The court is currently awaiting a psychiatric report. Andy Hill recently informed Justice Kiri Tahana that the expert’s report is currently half finished.

Expert Insight: When a defense is based on insanity, the trial shifts from a question of “did the defendant do it” to “what was the defendant’s mental state.” The reliance on psychiatric reports means that the timeline of the trial is often tethered to the availability and completion of specialized medical evaluations.

Trial Scheduling and Court Conflicts

A four-week trial was originally scheduled to start on February 15 of next year. However, that time slot was required for another adjourned High Court murder trial involving Credence Paripari Malcolm and another man regarding the death of Korrey Whyman.

Justice Tahana has set a new trial date for Jeffries for July 27 of next year. There remains a possibility that the original February date could be used if the other trial does not proceed.

Justice Tahana expressed concern regarding the number of expert witnesses involved in the Jeffries case, noting that all parties may need confirmation of the date by November.

Frequently Asked Questions

What is the current legal plea entered by Justin Jeffries?

Justin Jeffries has pleaded not guilty and is taking the case to trial on the grounds of insanity.

Why was the trial date moved to July 27?

The court needed to use the original February 15 date for another adjourned High Court murder trial involving Credence Paripari Malcolm and another man.

What additional charges is the defendant facing?

In addition to the triple murder charges, Jeffries is charged with wounding Adam Sour with intent to cause grievous bodily harm, unlawfully using a bank card, and entering a building with intent to commit an imprisonable offense.

How do court scheduling conflicts impact the delivery of justice for victims’ families?

0 comments
0 FacebookTwitterPinterestEmail
Health

INO DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action

by Chief Editor
written by Chief Editor

Inovio Pharmaceuticals Investors Face Deadline in Securities Class Action

Investors who purchased Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023, and December 26, 2025, may be eligible to participate in a securities class action lawsuit. A lead plaintiff deadline of April 7, 2026, has been set for those wishing to seize a leadership role in the litigation.

What’s at Stake? Allegations of Misleading Statements

The lawsuit alleges that Inovio Pharmaceuticals made false and/or misleading statements concerning the manufacturing of its CELLECTRA device and the timeline for submitting the INO-3107 Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA). Specifically, the suit claims the company lacked sufficient information to support claims regarding FDA accelerated approval or priority review, ultimately overstating the regulatory and commercial prospects of INO-3107.

Who is Rosen Law Firm?

Rosen Law Firm, a global investor rights law firm, is leading the charge in this case. The firm encourages investors to secure legal counsel before the April 7th deadline. Rosen Law Firm highlights its experience in securities class actions and shareholder derivative litigation, noting its track record of success, including achieving the largest ever securities class action settlement against a Chinese Company and being ranked among the top firms by ISS Securities Class Action Services.

Contingency Fee Arrangement: No Upfront Costs

Investors who purchased Inovio securities during the specified Class Period may be entitled to compensation without incurring any out-of-pocket fees or costs. The arrangement operates on a contingency fee basis, meaning legal fees are only paid if a recovery is obtained.

The Role of a Lead Plaintiff

The court must select a lead plaintiff to represent the interests of all class members. This individual or entity will be responsible for directing the litigation. Investors interested in serving as lead plaintiff must file a motion with the Court by April 7, 2026.

Why Choose Experienced Counsel?

Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions. The firm cautions investors to be wary of firms that act as “middlemen,” simply referring cases to other firms without directly handling the litigation. They highlight their global reach and concentration on complex securities litigation.

Navigating Securities Class Actions: A Growing Trend

Securities class action lawsuits are becoming increasingly common as investors seek redress for financial losses resulting from alleged corporate misconduct. These cases often involve complex financial instruments and require specialized legal expertise. The Inovio Pharmaceuticals case is part of a broader trend of investor litigation targeting pharmaceutical and biotechnology companies.

Did you know?

In 2019, Rosen Law Firm secured over $438 million for investors. Founding partner Laurence Rosen was named a Titan of Plaintiffs’ Bar by Law360 in 2020.

What Should Investors Do?

If you purchased Inovio Pharmaceuticals (INO) securities between October 10, 2023, and December 26, 2025, you have several options:

  • Join the class action: Submit your information through the Rosen Law Firm website.
  • Seek lead plaintiff status: File a motion with the Court by April 7, 2026.
  • Remain an absent class member: Do nothing at this time.
  • Retain your own counsel: You have the right to choose your own legal representation.

FAQ

Q: What is a securities class action?
A: A lawsuit filed on behalf of a group of investors who have suffered similar losses due to alleged fraudulent or misleading practices by a company.

Q: What is the deadline to join the Inovio Pharmaceuticals class action?
A: The lead plaintiff deadline is April 7, 2026.

Q: What does it signify to be a lead plaintiff?
A: A lead plaintiff represents the interests of all class members and directs the litigation.

Q: Will I have to pay anything upfront to join the lawsuit?
A: No, the lawsuit is being handled on a contingency fee basis, meaning you will only pay if a recovery is obtained.

Resources

To learn more about your legal options, contact Phillip Kim, Esq., toll-free at 866-767-3653 or via email at [email protected].

0 comments
0 FacebookTwitterPinterestEmail
Health

INO FINAL DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS LAWYERS, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

by Chief Editor
written by Chief Editor

Inovio Pharmaceuticals Investors Face Deadline in Securities Class Action

Investors who purchased Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023, and December 26, 2025, may be eligible to participate in a securities class action lawsuit. A lead plaintiff deadline of April 7, 2026, has been set for those wishing to take a leading role in the litigation.

What’s at Stake? Allegations of Misleading Statements

The lawsuit alleges that Inovio Pharmaceuticals made false and/or misleading statements regarding its CELLECTRA device manufacturing and the timeline for submitting its INO-3107 Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA). Specifically, the claim is that the company lacked sufficient information to justify accelerated approval or priority review for INO-3107, and that its overall regulatory and commercial prospects were overstated.

Who is Rosen Law Firm?

Rosen Law Firm, a global investor rights law firm, is leading the charge in this case. They specialize in securities class actions and shareholder derivative litigation, representing investors worldwide. The firm highlights its track record of success, including achieving the largest ever securities class action settlement against a Chinese Company and consistently ranking among the top firms in the field. They were ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

What Does This Mean for Investors?

If you purchased Inovio securities during the specified Class Period, you may be entitled to compensation without incurring out-of-pocket fees or costs, through a contingency fee arrangement. A lead plaintiff directs the litigation on behalf of other class members.

Navigating Securities Class Action Lawsuits: A Growing Trend

Securities class action lawsuits are becoming increasingly common, reflecting a heightened focus on corporate accountability and investor protection. These lawsuits often arise when companies are accused of misleading investors about their financial performance or business prospects. The Inovio case is part of this broader trend.

The Role of “Middlemen” Law Firms

Rosen Law Firm emphasizes the importance of selecting qualified counsel with a proven track record. They caution investors to be wary of firms that act merely as “middlemen,” referring clients to other firms that actually litigate the cases. This highlights a potential pitfall for investors seeking legal representation.

Contingency Fee Arrangements: How They Work

Contingency fee arrangements are standard in securities class action lawsuits. Which means investors do not pay legal fees upfront. Instead, the law firm receives a percentage of any recovery obtained through settlement or judgment. This arrangement makes legal representation accessible to a wider range of investors.

Key Dates and How to Participate

The crucial date to remember is April 7, 2026. Here’s the deadline for investors who wish to move the Court to serve as lead plaintiff. To join the Inovio class action, you can visit https://rosenlegal.com/submit-form/?case_id=52847, call Phillip Kim, Esq. Toll-free at 866-767-3653, or email [email protected].

FAQ

Q: What is a lead plaintiff?
A: A lead plaintiff is a representative party who directs the litigation on behalf of other class members.

Q: Do I have to be the lead plaintiff to benefit from the lawsuit?
A: No, an investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Q: What are the costs involved in joining the class action?
A: You may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.

Q: Is a class already certified?
A: No, a class has not yet been certified. You are not represented by counsel unless you retain one.

Did you realize? Rosen Law Firm has recovered hundreds of millions of dollars for investors.

Follow Rosen Law Firm on LinkedIn, Twitter, and Facebook for updates.

Pro Tip: Carefully consider your options and consult with legal counsel before making any decisions regarding your participation in this class action.

To learn more about this case and your potential rights, visit Rosen Law Firm’s website or contact Phillip Kim, Esq. Directly.

0 comments
0 FacebookTwitterPinterestEmail
News

Grant Organ lost control of his car, before he ‘fishtailed’, and crashed into tree, killing wife

by Rachel Morgan News Editor
written by Rachel Morgan News Editor

A man has pleaded guilty to a charge of careless driving causing the death of his wife following a crash in Waikato, New Zealand, on August 9, 2025. Julia Organ, 55, died at the scene after the vehicle she was travelling in left the road and collided with a tree.

Details of the Incident

The incident occurred at 9:11 am on State Highway 23 near Whatawhata as the family travelled towards Raglan. The road was wet despite sunny weather conditions. According to a summary of facts, three generations of the family were in the car: Julia Organ in the front passenger seat, their adult daughter in the back seat, and her 9-year-old son.

The driver, Grant Organ, 54, lost control of the vehicle even as navigating a moderate left-hand bend. The car slid sideways, crossed the centre line, rotated approximately 130 degrees, and left the road, ultimately impacting a tree on the passenger side.

Did You Know? The crash investigation determined that three generations of the Organ family were travelling in the vehicle at the time of the incident.

While the rear passengers were unharmed and taken to hospital as a precaution, Grant Organ sustained moderate injuries, including fractured ribs and vertebrae. He was initially trapped in the vehicle and required assistance from a bystander to be freed.

A serious crash unit investigation concluded that the crash was caused by the driver losing control and being unable to correct the vehicle’s rotation. While speed could not be definitively established, it could not be ruled out as a contributing factor. There was no evidence of driver distraction, impairment, or issues with the road or vehicle.

Legal Proceedings

Grant Organ appeared in the Hamilton District Court this week and pleaded guilty to the charge. His counsel, Ashleigh Beech, has indicated an intention to seek a discharge without conviction at the sentencing, which is scheduled for next month. He was remanded on bail.

Expert Insight: A plea of guilty, even with a potential application for a discharge without conviction, represents a significant legal step. The court will necessitate to weigh the seriousness of the offense against the defendant’s circumstances when considering sentencing.

Frequently Asked Questions

What caused the crash?

The serious crash unit investigation found the cause of the crash was the driver losing control of the car on a curve and being unable to correct the car’s rotation.

Were there any other injuries?

The rear passengers, an adult daughter and a 9-year-old child, were taken to hospital as a precaution but did not suffer any injuries. The driver, Grant Organ, sustained moderate injuries, including fractured ribs and vertebrae.

What is a section 106 discharge without conviction?

According to counsel, a section 106 discharge without conviction is a legal application that will be filed at sentencing. This means the court will consider whether to impose a conviction alongside any potential sentence.

What factors might a court consider when deciding whether to grant a discharge without conviction in this case?

0 comments
0 FacebookTwitterPinterestEmail
Entertainment

Rina Nose Nose Job: Before & After Transformation

by Chief Editor
written by Chief Editor

Rina Nose’s Nose Job: A Rising Trend in Indonesian Celebrity Culture?

Mauludi Rismoyo – detikHot

Monday, 09 Mar 2026 06:06 WIB

Jakarta – Indonesian artist Rina Nose has undergone a nose job, publicly sharing before-and-after photos on her Instagram account.

Rina Nose shared before-and-after photos of her nose following surgery on Instagram. (Photo: dok Instagram rinanose16)
rina nose
The change in Rina Nose’s nose shape is noticeable. (Photo: dok Instagram rinanose16)
rina nose
Rina Nose expressed her happiness with the results of the surgery. (Photo: dok Instagram rinanose16)
rina nose
Rina Nose’s nose job has generated buzz online. (Photo: dok Instagram rinanose16)

The Rise of Cosmetic Procedures Among Indonesian Celebrities

Rina Nose’s decision to publicly share her rhinoplasty is part of a growing trend among Indonesian celebrities. While cosmetic surgery has been present for years, increased social media usage and a greater emphasis on appearance have contributed to its normalization. This openness can influence public perception and potentially increase demand for similar procedures.

Social Media and the Pressure to Conform

The proliferation of social media platforms, particularly Instagram, has created a culture where visual presentation is paramount. Filters, editing tools, and the curated nature of online profiles contribute to unrealistic beauty standards. This can lead individuals, including public figures, to seek cosmetic enhancements to align with these perceived ideals.

Exploitation of Celebrity Events by Businesses

Interestingly, a hijab label recently leveraged a celebrity’s decision to remove her veil for a promotional offer. This demonstrates how brands are increasingly capitalizing on personal choices and public events to drive sales, raising ethical questions about the exploitation of personal narratives for commercial gain.

Fan Reactions and Shifting Public Opinion

Initial reactions to Rina Nose’s transformation have been mixed, with some fans expressing support and others voicing criticism. However, the immediate shift of Rina Nose gaining a fan in Fuji, as reported, suggests a potential for changing public opinion and acceptance of personal choices.

Beyond Rhinoplasty: Other Popular Procedures

While rhinoplasty is currently in the spotlight, other cosmetic procedures are also gaining popularity in Indonesia. These include facial fillers, botox injections, and various surgical enhancements. The demand for these procedures is driven by a desire to achieve a more youthful and aesthetically pleasing appearance.

The Role of Medical Professionals

The increasing demand for cosmetic procedures also highlights the importance of qualified and ethical medical professionals. Individuals considering surgery should thoroughly research their options and choose a reputable surgeon with a proven track record.

Pro Tip:

Always prioritize your health and well-being when considering cosmetic surgery. Consult with a qualified medical professional and carefully weigh the risks and benefits before making a decision.

FAQ

  • What is rhinoplasty? Rhinoplasty, commonly known as a nose job, is a surgical procedure to reshape the nose.
  • Is cosmetic surgery safe? Cosmetic surgery carries inherent risks, like any surgical procedure. Choosing a qualified surgeon and following post-operative instructions are crucial for minimizing complications.
  • How has social media impacted cosmetic surgery trends? Social media has increased awareness of cosmetic procedures and contributed to unrealistic beauty standards, driving demand for enhancements.

Explore more celebrity news and beauty trends on detikHot.

0 comments
0 FacebookTwitterPinterestEmail
Health

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

by Chief Editor
written by Chief Editor

Inovio Pharmaceuticals Investors Face Deadline in Securities Class Action

Investors who purchased Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023, and December 26, 2025, may be eligible to participate in a securities class action lawsuit. A lead plaintiff deadline of April 7, 2026, has been set for those wishing to direct the litigation.

What’s at Stake? Allegations of Misleading Statements

The lawsuit alleges that Inovio Pharmaceuticals made false and/or misleading statements regarding its business operations. Specifically, the claims center around issues with the manufacturing of the CELLECTRA device, delays in submitting the INO-3107 Biologics License Application (BLA) to the FDA, and overstated regulatory and commercial prospects for INO-3107. Investors reportedly suffered damages when these details came to light.

Key Allegations Detailed

  • Manufacturing Deficiencies: Concerns about the quality and reliability of the CELLECTRA device manufacturing process.
  • Delayed BLA Submission: Inovio was allegedly unlikely to submit its BLA for INO-3107 by the projected timeframe of the second half of 2024.
  • Questionable FDA Approval Path: Insufficient data to support accelerated or priority review by the FDA.
  • Overstated Prospects: An overly optimistic portrayal of the drug’s potential for regulatory success and market performance.

Rosen Law Firm Takes the Lead

Rosen Law Firm, a global investor rights law firm, is spearheading the class action. The firm encourages investors to select qualified counsel with a proven track record in securities litigation. They caution against firms that act merely as “middlemen,” referring cases to other firms without possessing the necessary expertise. Rosen Law Firm highlights its own success, including achieving the largest ever securities class action settlement against a Chinese Company and consistently ranking among the top firms in securities class action settlements.

The firm emphasizes its experience representing investors globally and its focus on securities class actions and shareholder derivative litigation. They have recovered hundreds of millions of dollars for investors, including over $438 million in 2019.

How to Participate and Important Considerations

If you purchased Inovio securities during the Class Period, you may be entitled to compensation without out-of-pocket fees through a contingency fee arrangement. To join the class action, you can:

If you wish to serve as lead plaintiff, you must file a motion with the Court by April 7, 2026. It’s important to note that a class has not yet been certified, and you are not automatically represented by counsel unless you retain one. You have the right to choose your own counsel or remain an absent class member.

The Rise of Securities Class Action Lawsuits

Securities class action lawsuits have become increasingly common in recent years, reflecting a growing awareness of investor rights and a more active legal landscape. These lawsuits often arise from allegations of corporate misconduct, such as misleading financial statements or inaccurate disclosures about product development. The potential for significant financial recovery makes these cases attractive to investors who believe they have been harmed by fraudulent or negligent behavior.

Did you know? The number of securities class action filings can fluctuate based on market conditions and regulatory enforcement activity. Periods of market volatility often see an increase in litigation.

FAQ

Q: What is a lead plaintiff?
A: A lead plaintiff is a representative party who directs the litigation on behalf of other class members.

Q: What is a contingency fee arrangement?
A: You only pay legal fees if the case is successful, and the fees are a percentage of the recovery.

Q: Do I have to be the lead plaintiff to receive compensation?
A: No, your ability to share in any potential recovery is not dependent on serving as lead plaintiff.

Q: What if I don’t want to participate?
A: You can remain an absent class member and do nothing at this time.

Pro Tip: Document all your Inovio Pharmaceuticals stock transactions during the Class Period. This information will be crucial if you decide to participate in the lawsuit.

Follow Rosen Law Firm for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

0 comments
0 FacebookTwitterPinterestEmail
Business

Australian watchdog warns petrol companies over Middle East fuel price hikes

by Chief Editor
written by Chief Editor

Australians Face Ongoing Petrol Price Volatility Amidst Global Uncertainty

Motorists across Australia are bracing for continued fluctuations at the bowser, with prices already surging in major cities and remote areas. The current increases are occurring despite warnings from the NRMA that oil companies are exploiting the ongoing Middle East crisis to inflate margins.

The Impact of Global Events on Local Prices

Recent bombings and retaliatory strikes involving Israel, Iran, and the U.S. Are contributing to anxieties about fuel supply and, prices. Even as it typically takes seven to ten days for global price shifts to be reflected domestically, some regions are already experiencing significant increases. Australians in remote areas are reportedly paying as much as A$4 ($4.76) per litre, while prices in Sydney, Brisbane, and Melbourne are rapidly climbing.

Price Gouging Accusations and Calls for Intervention

Peter Khoury, a spokesperson for the NRMA, has strongly condemned the price hikes, labeling them “ridiculous” price gouging. He asserts that fuel retailers are using the Middle East conflict as a pretext to increase profits. Khoury has urged the Australian Competition and Consumer Commission (ACCC) to intervene and halt what he describes as unjustifiable price increases.

“The servos and operators who are inflating prices know who they are. This must stop immediately,” Khoury stated.

ACCC Monitoring and Legal Reminders

The ACCC has confirmed it is closely monitoring petrol prices and has issued letters to several petrol companies, reminding them of their obligations under Australian Consumer Law. Commissioner Anna Brakey emphasized that misleading consumers about the reasons for price increases would be a breach of the law. The commission has pledged to take action against any company found to be violating competition and consumer laws.

Political Pressure on Fuel Companies

The rising prices have also drawn criticism from political leaders. Western Australian Premier Roger Cook cautioned fuel companies against capitalizing on public anxieties, stating they have “sustainable supplies of fuel for the moment” and should refrain from unnecessary price hikes.

Southeast Queensland Defies Expected Price Dip

Contrary to expectations of a price low this week, 210 service stations in Southeast Queensland actually increased their prices per litre, demonstrating a widespread trend of upward pressure on fuel costs.

What Does the Future Hold for Australian Petrol Prices?

The NRMA warns that there is “no end in sight” to the fluctuating petrol prices. The ongoing instability in the Middle East suggests continued volatility in global oil markets, which will likely translate to unpredictable prices at the pump for Australian consumers. The situation highlights the vulnerability of the Australian fuel market to international events and the potential for retailers to exploit these circumstances.

Did you know?

Petrol prices in Australia are influenced by a complex interplay of factors, including global oil prices, the Australian dollar exchange rate, refining costs, and retail margins.

Frequently Asked Questions

  • Why are petrol prices rising now? Petrol prices are rising due to increased global oil prices, largely influenced by conflict in the Middle East, and concerns about supply disruptions.
  • Is the ACCC doing anything about it? The ACCC is monitoring prices closely and has reminded petrol companies of their obligations under Australian law.
  • Will prices come down soon? The NRMA has warned there is no immediate end in sight to the fluctuating prices.

Pro Tip: Consider using fuel comparison apps to find the cheapest petrol in your area. These apps can help you save money on every fill-up.

Stay informed about the latest developments in fuel prices and consumer rights by visiting the NRMA website and the ACCC website.

What are your thoughts on the current petrol prices? Share your experiences and concerns in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

by Chief Editor
written by Chief Editor

Inovio Pharmaceuticals Investors Face Deadline in Securities Fraud Lawsuit

Investors who purchased Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023, and December 26, 2025, may be eligible to join a class action lawsuit. A lead plaintiff deadline of April 7, 2026, has been set, according to Rosen Law Firm, a global investor rights firm.

What’s at Stake? Allegations of Misleading Statements

The lawsuit alleges that Inovio Pharmaceuticals made false and/or misleading statements regarding its CELLECTRA device manufacturing and the potential approval timeline for its INO-3107 drug. Specifically, the claims center around concerns that:

  • Manufacturing processes for the CELLECTRA device were deficient.
  • The company was unlikely to submit a Biologics License Application (BLA) for INO-3107 to the FDA by the second half of 2024.
  • Inovio lacked sufficient data to support accelerated or priority review by the FDA.
  • The overall regulatory and commercial prospects of INO-3107 were overstated.

These alleged misrepresentations, if proven, could have led investors to suffer damages when the true details came to light.

Who is Rosen Law Firm and Why Should Investors Pay Attention?

Rosen Law Firm is actively soliciting investors to potentially serve as lead plaintiff in the case. The firm emphasizes its experience in securities class actions and shareholder derivative litigation, highlighting a track record of success, including achieving the largest ever securities class action settlement against a Chinese Company and being ranked No. 1 by ISS Securities Class Action Services in 2017 for the number of settlements achieved. They caution investors to carefully select legal counsel, noting that some firms act as “middlemen” rather than directly litigating cases.

Understanding Class Action Lawsuits and Lead Plaintiffs

A class action lawsuit allows a group of investors who have suffered similar losses to collectively pursue legal action. The lead plaintiff represents the interests of all class members. If you wish to serve as lead plaintiff, you must file a motion with the Court no later than April 7, 2026.

How Can Investors Participate?

Investors who purchased Inovio securities during the specified Class Period can explore their options by:

It’s important to note that participation does not require out-of-pocket fees, as the firm operates on a contingency fee arrangement.

The Rise of Securities Class Action Lawsuits: A Growing Trend

Securities class action lawsuits have become increasingly common in recent years, reflecting heightened investor awareness and scrutiny of corporate disclosures. Several factors contribute to this trend:

  • Increased Market Volatility: Periods of market turbulence often expose vulnerabilities in company performance and lead to investor losses.
  • Complex Financial Instruments: The growing complexity of financial products can make it difficult for investors to fully understand the risks involved.
  • Regulatory Scrutiny: Increased regulatory oversight and enforcement actions can uncover instances of corporate misconduct.

Pro Tip:

Don’t delay if you believe you may have been affected by this lawsuit. The lead plaintiff deadline is a firm date, and missing it could impact your ability to participate in any potential recovery.

FAQ

Q: What is a “Class Period”?
A: The Class Period refers to the specific timeframe during which investors may have been harmed by the alleged misconduct. In this case, it’s October 10, 2023, to December 26, 2025.

Q: Do I need to hire my own lawyer?
A: No, you can remain an absent class member and do nothing at this time. Though, you have the option to select your own counsel if you prefer.

Q: Will I have to pay anything to join the lawsuit?
A: No, Rosen Law Firm operates on a contingency fee basis, meaning you will not pay any out-of-pocket fees or costs.

Q: What does it mean to be a “lead plaintiff”?
A: The lead plaintiff is the representative party who directs the litigation on behalf of all class members.

Q: Is there a guarantee of recovery?
A: No, there is no guarantee of recovery in any class action lawsuit. The outcome depends on the specific facts of the case and the evidence presented.

Follow Rosen Law Firm for updates on LinkedIn, Twitter, or Facebook.

Attorney Advertising. Prior results do not guarantee a similar outcome.

0 comments
0 FacebookTwitterPinterestEmail
Business

West Coast Lotto ticket holders discover they are unclaimed $5.08m winner

by Chief Editor
written by Chief Editor

West Coast Couple’s $5 Million Lotto Win: A Reminder of New Zealand’s Lottery Culture

A West Coast couple recently experienced a life-altering moment when they discovered they’d won $5.08 million in the Lotto Powerball draw held on February 14th. The win, claimed at New World Greymouth, highlights the enduring appeal of lotteries in New Zealand and the often-surreal reactions that accompany such good fortune.

The Serendipitous Check

The couple’s win was almost accidental. They hadn’t initially realized a significant prize remained unclaimed in their region. It was a casual mention by the man’s sister that sparked the idea to check their ticket. A few days later, while running errands, he stopped at New World Greymouth. The supermarket operator’s reaction – calmly closing the counter and escorting him to the office – signaled the magnitude of his win. “The look on the operator’s face will stay with me forever,” he recalled.

A Wave of Emotion

The initial shock was profound. The man struggled to comprehend the numbers, experiencing shaking hands, and disbelief. He immediately attempted to share the news with his partner, who was gardening at the time and missed the initial calls. The confirmation came via a photo of the winning paperwork, followed by a hushed plea: “Whatever you do, don’t tell anyone.” The drive home was described as one of heightened awareness, reminiscent of bringing a newborn baby home from the hospital.

Celebrating with Chocolate Biscuits

Despite the immense windfall, the couple’s initial celebration was remarkably understated – a quiet moment shared over a couple of chocolate biscuits. This down-to-earth reaction reflects their grounded nature and the overwhelming emotion of the moment. They are still processing the news and contemplating their future.

Part of a Larger $15 Million Jackpot

This $5.08 million prize was one of three portions of a $15 million Powerball jackpot drawn on February 14th. The other winning tickets were sold in Paraparaumu (Coastlands Lotto) and via MyLotto. A Masterton man and a grandfather from Paraparaumu also claimed $5.08 million prizes, each with their own unique stories of discovery.

The Allure of the Lottery in New Zealand

Lotteries have a long and established history in New Zealand, offering a dream of financial freedom to countless individuals. While the odds of winning remain slim, the potential reward continues to captivate the public. The Lotto New Zealand website provides information on responsible gambling and support services.

Future Plans: Mortgage-Free and Renovations

The West Coast couple’s immediate plans are practical and sensible: paying off their mortgage and undertaking some home renovations. They also expressed a desire to travel in the future, though their wishlist remains modest. Their story serves as a reminder that a lottery win can provide security and opportunities, but it doesn’t necessarily change fundamental values.

Frequently Asked Questions

What is the Lotto Powerball?

Lotto Powerball is a New Zealand lottery game offering large jackpots. Players select numbers, and if they match the drawn numbers, they win a prize.

Where can I check my Lotto ticket?

You can check your ticket at any Lotto retailer, including supermarkets like New World, or online through the MyLotto website.

What should I do if I win the lottery?

It’s advisable to sign the back of your ticket, keep it safe, and contact Lotto New Zealand as soon as possible to claim your prize.

Is gambling addictive?

Yes, gambling can be addictive. If you or someone you know is struggling with problem gambling, help is available. Visit the Problem Gambling Foundation website for support.

Did you know? The $15 million Powerball jackpot drawn on February 14th was split three ways, with each winning ticket receiving $5.08 million.

Pro Tip: Always check your Lotto tickets, even if you don’t remember buying them. You never know – you might be a winner!

We’d love to hear your thoughts! Share your own lottery stories or dreams in the comments below. For more inspiring stories and financial news, be sure to explore our other articles.

0 comments
0 FacebookTwitterPinterestEmail
Tech

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Richtech Robotics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm

by Chief Editor
written by Chief Editor

Richtech Robotics Lawsuit: What Investors Necessitate to Know

Rosen Law Firm is encouraging investors who purchased securities of Richtech Robotics Inc. (NASDAQ: RR) between January 27, 2026, and January 29, 2026, to secure legal counsel. This follows the filing of a securities class action lawsuit alleging false and misleading statements made by the company.

The Allegations: Misleading Claims About Microsoft Collaboration

The lawsuit centers around claims that Richtech Robotics falsely stated it had a collaborative and commercial relationship with Microsoft. According to the filing, this alleged misrepresentation impacted the company’s reported business operations and future prospects. Investors are claiming that when the truth emerged, they suffered financial damages.

Understanding Securities Class Action Lawsuits

Securities class action lawsuits are a legal mechanism allowing a group of investors to collectively seek compensation for losses resulting from fraudulent or misleading corporate practices. These cases often involve allegations of false statements in financial reports or public communications.

Key Dates and Deadlines for Investors

A crucial date for potential plaintiffs is April 3, 2026. What we have is the deadline to move the Court to serve as lead plaintiff in the class action. A lead plaintiff directs the litigation on behalf of other class members.

Why Choose Experienced Counsel? Rosen Law Firm’s Track Record

Rosen Law Firm emphasizes the importance of selecting qualified legal representation with a proven track record in securities litigation. The firm highlights concerns about firms that act as “middlemen,” simply referring cases to other attorneys. Rosen Law Firm boasts a history of success, including achieving the largest ever securities class action settlement against a Chinese Company, and consistently ranking among the top firms in securities class action settlements. In 2019, the firm secured over $438 million for investors, and founding partner Laurence Rosen was named a Titan of Plaintiffs’ Bar in 2020.

How to Join the Richtech Robotics Class Action

Investors who purchased Richtech Robotics securities during the specified Class Period may be eligible for compensation without upfront costs through a contingency fee arrangement. To learn more or join the class action, investors can visit https://rosenlegal.com/submit-form/?case_id=51742, call Phillip Kim, Esq. Toll-free at 866-767-3653, or email [email protected].

What Happens Next? The Litigation Process

The legal process involves several stages, including discovery, where evidence is gathered, and potential settlement negotiations. It’s important to remember that no class has been certified yet. Until certification, investors are not automatically represented by counsel and can choose their own legal representation.

FAQ: Richtech Robotics Securities Litigation

  • What is the Class Period? The Class Period is between January 27, 2026 and 12:00 PM ET on January 29, 2026.
  • What is a lead plaintiff? A lead plaintiff is a representative party who directs the litigation on behalf of other class members.
  • Is there a cost to join the lawsuit? No, the firm operates on a contingency fee basis, meaning there are no upfront costs.
  • Do I have to be the lead plaintiff to receive compensation? No, an investor’s ability to share in any potential recovery is not dependent on serving as lead plaintiff.

Pro Tip: Document all your Richtech Robotics stock transactions during the Class Period. This documentation will be crucial if you decide to participate in the lawsuit.

Stay informed about this case and other investor rights issues by following Rosen Law Firm on LinkedIn, Twitter, and Facebook.

Attorney Advertising. Prior results do not guarantee a similar outcome.

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts